The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

They also don’t directly support behavior change, which Kathryn Ilonka Pollak, PhD, a professor in population health sciences ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

Rising consumer demand for fewer empty calories is pushing the snack and beverage giant to offer options with less sodium, ...

Under the patronage of His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the United Arab Emirates, His Highness ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Use of a sodium-glucose cotransporter 2, or SGLT2, inhibitor combined with calorie restriction resulted in greater rates of type 2 diabetes remission compared with calorie restriction alone, according ...